News
Cantor Fitzgerald Lowers PT on Centene Corporation (CNC) to $65 From $90, Keeps an Overweight Rating
Centene Corporation (NYSE: CNC) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On July 2, Cantor ...
Sundar Subramanian, a partner at PricewaterhouseCoopers (PwC) consulting affiliate Strategy&, has joined population health ...
HBM, STNE, CNC, and CVS stand out for low P/CF ratios and strong value scores as investors seek quality in a cautious market.
The Dow Jones Industrial Average stood out yesterday, climbing 0.91%, as market participants repositioned portfolios at the start of the second half of 2025. On the contrary, the S&P 500 and Nasdaq ...
Centene leads the Medicaid (low-income) managed care business, which accounts for about 60% of its medical membership. The Affordable Care Act expanded the Medicaid population starting in 2014, and ...
The 25% decline in Centene’s stock seems warranted given the substantial earnings adjustment and ongoing ambiguity. With more state data still forthcoming and the threat of additional earnings ...
Centene Corporation (NYSE: CNC), a leading diversified healthcare company currently trading near its 52-week low of $54.01, finds itself at a crossroads as it navigates a complex regulatory ...
Our Pro platform offers fair value estimates, performance predictions, and risk assessments, along with additional tips and expert analysis. Explore CNC’s full potential at InvestingPro.
Get a deeper insight into the potential performance of Centene (CNC) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for ...
Our Pro platform offers fair value estimates, performance predictions, and risk assessments, along with additional tips and expert analysis. Explore CNC’s full potential at InvestingPro.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results